ALL (Acute Lymphoblastic Leukemia),Leukemia Cytotoxic Drug Impact on Pediatric B-ALL Immunophenotype Mar 12, 2024
AML (Acute Myeloid Leukemia),Leukemia RARα & PPARβ/δ Expression in MDS: Prognostic Insights Mar 11, 2024
CML (Chronic Myeloid Leukemia),Leukemia Signaling Pathways and TKI Resistance in CML Patients Mar 08, 2024
AML (Acute Myeloid Leukemia),CML (Chronic Myeloid Leukemia),Leukemia 9GY TMI With FLUBU4: Promising Myeloid Malignancy Outcomes Mar 07, 2024
ALL (Acute Lymphoblastic Leukemia),Leukemia Allopurinol Improves Mercaptopurine Safety in Pediatric ALL Mar 06, 2024
AML (Acute Myeloid Leukemia),Leukemia AML B-Cell Profiling: Implications for Immunotherapy Mar 05, 2024
AML (Acute Myeloid Leukemia),Leukemia Enasidenib Maintenance in mIDH2 AML: Safe & Effective Mar 01, 2024
